2024-2028 年避孕環全球市場

概述

預計從 2023 年到 2028 年，避孕環市場將成長 7.4836 億美元，預測期內複合年成長率為 5.78%。

該報告包括對避孕環市場的總體分析、市場規模和預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。消費者對避孕藥具的進步觀點普及、計劃生育的重要性日益增加以及非避孕藥具的健康益處推動了市場的發展。

研究認為，高可支配收入是未來幾年推動避孕環市場成長的關鍵因素之一。此外，不斷增加的創新行銷策略和對長效避孕藥需求的增加導致市場需求強勁。

目錄

第1章執行摘要

• 市場概況

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 細分市場分析
• 2023 年市場規模
• 2023-2028年市場展望

第4章 市場規模表現

• 2018-2022年全球避孕環市場
• 2018-2022年配銷通路細分分析
• 2018-2022 年最終用戶細分分析
• 2018-2022 年區域細分分析
• 2018-2022 年國家細分分析

第5章五力分析

• 五力摘要
• 買方議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第6章市場區隔：按配銷通路

• 細分市場
• 比較：按配銷通路
• 藥局與診所：2023-2028 年市場規模與預測
• 線上零售：2023-2028 年市場規模與預測
• 市場機會：依配銷通路

第7章市場區隔：依最終用戶

• 細分市場
• 比較：按最終用戶
• 醫院：2023-2028 年市場規模與預測
• 婦科診所：2023-2028年市場規模及預測
• 其他：2023-2028年市場規模與預測
• 市場機會：依最終用戶分類

第8章 客戶形勢

• 客戶形勢概覽

第9章 地區形勢

• 區域細分
• 區域比較
• 北美：2023-2028 年市場規模與預測
• 歐洲：2023-2028 年市場規模與預測
• 亞洲：2023-2028年市場規模與預測
• 世界其他地區：2023-2028 年市場規模與預測
• 美國：2023-2028 年市場規模與預測
• 加拿大：2023-2028 年市場規模與預測
• 德國：2023-2028 年市場規模與預測
• 英國：2023-2028 年市場規模與預測
• 法國：2023-2028年市場規模與預測
• 市場機會：依地區形勢

第 10 章 促進因素、挑戰與趨勢

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場趨勢

第11章 供應商形勢

• 概述
• 供應商形勢
• 混亂的情況
• 產業風險

第12章供應商分析

• 交易廠商
• 供應商市場定位
• AbbVie Inc.
• Bayer AG
• Bos Medicare Surgical
• EUROGINE SL
• Johnson and Johnson
• Mayne Pharma Group Ltd.
• Merck and Co. Inc.
• Mithra Pharmaceuticals SA
• Novo Nordisk AS
• Pfizer Inc.
• Prasco Laboratories
• QPharma Inc.
• SMB Corp. of India
• Teva Pharmaceutical Industries Ltd.
• TherapeuticsMD Inc.

第13章附錄

Abstract

The vaginal ring market is forecasted to grow by USD 748.36 mn during 2023-2028, accelerating at a CAGR of 5.78% during the forecast period. The report on the vaginal ring market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the progressive perspective of consumers toward contraceptives, the growing importance of family planning, and non-contraceptive health benefits.

Technavio's vaginal ring market is segmented as below:

By Distribution Channel

• Pharmacies and clinics
• Online retail

By End-user

• Hospitals
• Gynecology clinics
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the high disposable income as one of the prime reasons driving the vaginal ring market growth during the next few years. Also, an increase in innovative marketing strategies and increasing demand for long-acting contraceptives will lead to sizable demand in the market.

The report on the vaginal ring market covers the following areas:

• Vaginal ring market sizing
• Vaginal ring market forecast
• Vaginal ring market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaginal ring market vendors that include AbbVie Inc., Allergan, Bayer AG, Bos Medicare Surgical, EUROGINE SL, Johnson and Johnson, Mayne Pharma Group Ltd., Merck and Co. Inc., Mithra Pharmaceuticals SA, Novo Nordisk AS, Pfizer Inc., Prasco Laboratories, QPharma Inc., Searchlight Pharma Inc., SMB Corp. of India, Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc.. Also, the vaginal ring market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global vaginal ring market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global vaginal ring market 2018 - 2022 ($ million)
• 4.2 Distribution Channel Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Distribution Channel

• 6.1 Market segments
• Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
• 6.2 Comparison by Distribution Channel
• Exhibit 32: Chart on Comparison by Distribution Channel
• Exhibit 33: Data Table on Comparison by Distribution Channel
• 6.3 Pharmacies and clinics - Market size and forecast 2023-2028
• Exhibit 34: Chart on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
• 6.4 Online retail - Market size and forecast 2023-2028
• Exhibit 38: Chart on Online retail - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Online retail - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Online retail - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Online retail - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Distribution Channel
• Exhibit 42: Market opportunity by Distribution Channel ($ million)
• Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 46: Chart on Comparison by End-user
• Exhibit 47: Data Table on Comparison by End-user
• 7.3 Hospitals - Market size and forecast 2023-2028
• Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 7.4 Gynecology clinics - Market size and forecast 2023-2028
• Exhibit 52: Chart on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Gynecology clinics - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Gynecology clinics - Year-over-year growth 2023-2028 (%)
• 7.5 Others - Market size and forecast 2023-2028
• Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.6 Market opportunity by End-user
• Exhibit 60: Market opportunity by End-user ($ million)
• Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 65: Chart on Geographic comparison
• Exhibit 66: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Canada - Market size and forecast 2023-2028
• Exhibit 87: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.9 Germany - Market size and forecast 2023-2028
• Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 France - Market size and forecast 2023-2028
• Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 103: Market opportunity By Geographical Landscape ($ million)
• Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 105: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 107: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 108: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 109: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 110: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 111: AbbVie Inc. - Overview
• Exhibit 112: AbbVie Inc. - Product / Service
• Exhibit 113: AbbVie Inc. - Key news
• Exhibit 114: AbbVie Inc. - Key offerings
• 12.4 Bayer AG
• Exhibit 115: Bayer AG - Overview
• Exhibit 116: Bayer AG - Business segments
• Exhibit 117: Bayer AG - Key news
• Exhibit 118: Bayer AG - Key offerings
• Exhibit 119: Bayer AG - Segment focus
• 12.5 Bos Medicare Surgical
• Exhibit 120: Bos Medicare Surgical - Overview
• Exhibit 121: Bos Medicare Surgical - Key offerings
• 12.6 EUROGINE SL
• Exhibit 122: EUROGINE SL - Overview
• Exhibit 123: EUROGINE SL - Product / Service
• Exhibit 124: EUROGINE SL - Key offerings
• 12.7 Johnson and Johnson
• Exhibit 125: Johnson and Johnson - Overview
• Exhibit 126: Johnson and Johnson - Business segments
• Exhibit 127: Johnson and Johnson - Key news
• Exhibit 128: Johnson and Johnson - Key offerings
• Exhibit 129: Johnson and Johnson - Segment focus
• 12.8 Mayne Pharma Group Ltd.
• Exhibit 130: Mayne Pharma Group Ltd. - Overview
• Exhibit 131: Mayne Pharma Group Ltd. - Business segments
• Exhibit 132: Mayne Pharma Group Ltd. - Key news
• Exhibit 133: Mayne Pharma Group Ltd. - Key offerings
• Exhibit 134: Mayne Pharma Group Ltd. - Segment focus
• 12.9 Merck and Co. Inc.
• Exhibit 135: Merck and Co. Inc. - Overview
• Exhibit 136: Merck and Co. Inc. - Business segments
• Exhibit 137: Merck and Co. Inc. - Key news
• Exhibit 138: Merck and Co. Inc. - Key offerings
• Exhibit 139: Merck and Co. Inc. - Segment focus
• 12.10 Mithra Pharmaceuticals SA
• Exhibit 140: Mithra Pharmaceuticals SA - Overview
• Exhibit 141: Mithra Pharmaceuticals SA - Product / Service
• Exhibit 142: Mithra Pharmaceuticals SA - Key offerings
• 12.11 Novo Nordisk AS
• Exhibit 143: Novo Nordisk AS - Overview
• Exhibit 144: Novo Nordisk AS - Business segments
• Exhibit 145: Novo Nordisk AS - Key offerings
• Exhibit 146: Novo Nordisk AS - Segment focus
• 12.12 Pfizer Inc.
• Exhibit 147: Pfizer Inc. - Overview
• Exhibit 148: Pfizer Inc. - Product / Service
• Exhibit 149: Pfizer Inc. - Key news
• Exhibit 150: Pfizer Inc. - Key offerings
• 12.13 Prasco Laboratories
• Exhibit 151: Prasco Laboratories - Overview
• Exhibit 152: Prasco Laboratories - Product / Service
• Exhibit 153: Prasco Laboratories - Key offerings
• 12.14 QPharma Inc.
• Exhibit 154: QPharma Inc. - Overview
• Exhibit 155: QPharma Inc. - Product / Service
• Exhibit 156: QPharma Inc. - Key offerings
• 12.15 SMB Corp. of India
• Exhibit 157: SMB Corp. of India - Overview
• Exhibit 158: SMB Corp. of India - Product / Service
• Exhibit 159: SMB Corp. of India - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 160: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 161: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 164: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 TherapeuticsMD Inc.
• Exhibit 165: TherapeuticsMD Inc. - Overview
• Exhibit 166: TherapeuticsMD Inc. - Product / Service
• Exhibit 167: TherapeuticsMD Inc. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 168: Inclusions checklist
• Exhibit 169: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 170: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 171: Research methodology
• Exhibit 172: Validation techniques employed for market sizing
• Exhibit 173: Information sources
• 13.5 List of abbreviations
• Exhibit 174: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global vaginal ring market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
• Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Distribution Channel
• Exhibits33: Data Table on Comparison by Distribution Channel
• Exhibits34: Chart on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Pharmacies and clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Pharmacies and clinics - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Online retail - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Online retail - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Online retail - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Online retail - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Distribution Channel ($ million)
• Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits44: Chart on End-user - Market share 2023-2028 (%)
• Exhibits45: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by End-user
• Exhibits47: Data Table on Comparison by End-user
• Exhibits48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Gynecology clinics - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Gynecology clinics - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Gynecology clinics - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits60: Market opportunity by End-user ($ million)
• Exhibits61: Data Table on Market opportunity by End-user ($ million)
• Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits65: Chart on Geographic comparison
• Exhibits66: Data Table on Geographic comparison
• Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on France - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on France - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits103: Market opportunity By Geographical Landscape ($ million)
• Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits105: Impact of drivers and challenges in 2023 and 2028
• Exhibits106: Overview on Criticality of inputs and Factors of differentiation
• Exhibits107: Overview on factors of disruption
• Exhibits108: Impact of key risks on business
• Exhibits109: Vendors covered
• Exhibits110: Matrix on vendor position and classification
• Exhibits111: AbbVie Inc. - Overview
• Exhibits112: AbbVie Inc. - Product / Service
• Exhibits113: AbbVie Inc. - Key news
• Exhibits114: AbbVie Inc. - Key offerings
• Exhibits115: Bayer AG - Overview
• Exhibits116: Bayer AG - Business segments
• Exhibits117: Bayer AG - Key news
• Exhibits118: Bayer AG - Key offerings
• Exhibits119: Bayer AG - Segment focus
• Exhibits120: Bos Medicare Surgical - Overview
• Exhibits121: Bos Medicare Surgical - Key offerings
• Exhibits122: EUROGINE SL - Overview
• Exhibits123: EUROGINE SL - Product / Service
• Exhibits124: EUROGINE SL - Key offerings
• Exhibits125: Johnson and Johnson - Overview
• Exhibits126: Johnson and Johnson - Business segments
• Exhibits127: Johnson and Johnson - Key news
• Exhibits128: Johnson and Johnson - Key offerings
• Exhibits129: Johnson and Johnson - Segment focus
• Exhibits130: Mayne Pharma Group Ltd. - Overview
• Exhibits131: Mayne Pharma Group Ltd. - Business segments
• Exhibits132: Mayne Pharma Group Ltd. - Key news
• Exhibits133: Mayne Pharma Group Ltd. - Key offerings
• Exhibits134: Mayne Pharma Group Ltd. - Segment focus
• Exhibits135: Merck and Co. Inc. - Overview
• Exhibits136: Merck and Co. Inc. - Business segments
• Exhibits137: Merck and Co. Inc. - Key news
• Exhibits138: Merck and Co. Inc. - Key offerings
• Exhibits139: Merck and Co. Inc. - Segment focus
• Exhibits140: Mithra Pharmaceuticals SA - Overview
• Exhibits141: Mithra Pharmaceuticals SA - Product / Service
• Exhibits142: Mithra Pharmaceuticals SA - Key offerings
• Exhibits143: Novo Nordisk AS - Overview
• Exhibits144: Novo Nordisk AS - Business segments
• Exhibits145: Novo Nordisk AS - Key offerings
• Exhibits146: Novo Nordisk AS - Segment focus
• Exhibits147: Pfizer Inc. - Overview
• Exhibits148: Pfizer Inc. - Product / Service
• Exhibits149: Pfizer Inc. - Key news
• Exhibits150: Pfizer Inc. - Key offerings
• Exhibits151: Prasco Laboratories - Overview
• Exhibits152: Prasco Laboratories - Product / Service
• Exhibits153: Prasco Laboratories - Key offerings
• Exhibits154: QPharma Inc. - Overview
• Exhibits155: QPharma Inc. - Product / Service
• Exhibits156: QPharma Inc. - Key offerings
• Exhibits157: SMB Corp. of India - Overview
• Exhibits158: SMB Corp. of India - Product / Service
• Exhibits159: SMB Corp. of India - Key offerings
• Exhibits160: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits161: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits162: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits163: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits164: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits165: TherapeuticsMD Inc. - Overview
• Exhibits166: TherapeuticsMD Inc. - Product / Service
• Exhibits167: TherapeuticsMD Inc. - Key offerings
• Exhibits168: Inclusions checklist
• Exhibits169: Exclusions checklist
• Exhibits170: Currency conversion rates for US$
• Exhibits171: Research methodology
• Exhibits172: Validation techniques employed for market sizing
• Exhibits173: Information sources
• Exhibits174: List of abbreviations